VIR BIOTECHNOLOGY, I

VIR
Delayed Quote. Delayed  - 07/30 04:00:00 pm
35.65USD -2.03%

Turn to zoom
Prev.36.3900
Open36.1700
High36.3100
Low35.2100
Volume479 163
Latest news
2d ago
3d ago
3d ago
3d ago
Chart VIR BIOTECHNOLOGY, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishNeutral
Resistance41,649,676,6
Spread/Res.-14%-28%-53%
Spread/Supp.0,65%0,65%33%
Support35,435,426,8
Financials
Sales 2021 284 M - -
Net income 2021 -331 M - -
Net cash 2021 364 M - -
P/E ratio 2021 -13,5x
Yield 2021 -
Capitalization 4 636 M 4 636 M -
EV / Sales 2021 15,1x
EV / Sales 2022 8,47x
Nbr of Employees 340
Free-Float 86,9%
Company
Vir Biotechnology, Inc. is a clinical-stage immunology company. The Company is focused on developing treatments to treat and prevent serious infectious diseases. Its technology platforms are focused on antibodies, T cells, innate immunity and small interfering ribonucleic acid (siRNA). Its pipeline...

>> Read more
Sector :
Other Biotechnology & Medical Research
Calendar :
2021-08-05 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 35,65 $
Average target price 74,29 $
Spread / Average Target 108%